Skip to content

Comparison of ankle replacement and supramalleolar osteotomy in the treatment of stage 3B ankle arthritis: a prospective randomized controlled trial

Comparison of ankle replacement and supramalleolar osteotomy in the treatment of stage 3B ankle arthritis: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067107
Enrollment
Unknown
Registered
2022-12-27
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis of ankle

Interventions

TAR group:total ankle replacement
SMO group:Supramalleolar Osteotomy

Sponsors

West China hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1) The patient was diagnosed as Takakura Stage IIIb ankle arthritis by preoperative X-ray and CT examination; (2)BMI=30 (3) Willing to cooperate with surgery and regular follow-up; (4) Able to accept random allocation of two surgical methods and bear relevant medical expenses;

Exclusion criteria

Exclusion criteria: (1) Under 18 years old (2) Heavy manual workers (3) Hip and knee joint diseases (4) Endocrine, rheumatic and immune system diseases such as rheumatoid arthritis, compulsory spondylitis and uncontrolled gout (5) Alcoholism and smoking (6) Uncontrolled diabetes patients, Especially for those who have been complicated with diabetes peripheral neuropathy (7) Poor soft tissue conditions around the ankle (8) Systemic or local infection (9) Poor local blood circulation of the ankle (10) Severe bone defect of the ankle (11) Severe instability of the ankle (12) Severe cardiovascular and cerebrovascular diseases (13) Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
TAS;AOFAS;rate of bone union;Patient satisfaction;VAS;total charge;Failure rate of operation;Prosthesis survival time;

Countries

China

Contacts

Public ContactZhang Hui

West China hospital of Sichuan University

caesarzh@163.com18980601437

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026